Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9ECS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,471
Award facts
- Contract value 100% obligated
- $51,470.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $51,470.52 from the Defense Logistics Agency (DLA) on January 30, 2026, for the supply of DESCOVY 200-25 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by February 2, 2026. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly doing business as Amerisourcebergen), which holds the prime IDC relationship with the Defense Logistics Agency. The parent company, Cencora, maintains an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, enabling the supply of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and veteran healthcare programs globally. This delivery order for DESCOVY aligns with the company's established role as a critical vendor for federal medical procurement, particularly for the Defense Health Agency and related government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9ECS?
SPE2DR26F9ECS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9ECS worth?
The government has obligated $51,471 on SPE2DR26F9ECS.
Is contract SPE2DR26F9ECS an order under another contract?
Yes. SPE2DR26F9ECS is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9ECS competed?
The extent of competition for SPE2DR26F9ECS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award